MEF2C TRANSCRIPTION FACTOR IS ASSOCIATED WITH THE GENETIC AND EPIGENETIC RISK ARCHITECTURE OF SCHIZOPHRENIA AND IMPROVES COGNITION IN MICE

Large scale consortia mapping the genomic risk architectures of schizophrenia provide vast amounts of molecular information, with largely unexplored therapeutic potential. We harnessed publically available information from the Psychiatric Genomics Consortium, and report MYOCYTE ENHANCER FACTOR 2C (M...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Psychiatry
Autors principals: Mitchell, Amanda C., Javidfar, Behnam, Pothula, Venu, Ibi, Daisuke, Shen, Erica Y., Peter, Cyril J., Bicks, Lucy, Fehr, Tristan, Jiang, Yan, Brennand, Kristen J., Neve, Rachael L., Gonzalez-Maeso, Javier, Akbarian, Schahram
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5966823/
https://ncbi.nlm.nih.gov/pubmed/28115742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mp.2016.254
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars